Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices

Yorihiko Matsumoto, Satsuki Fukushima, Yusuke Shimahara, Naonori Kawamoto, Naoki Tadokoro, Kensuke Kuroda, Seiko Nakajima, Takuya Watanabe, Osamu Seguchi, Masanobu Yanase, Norihide Fukushima, Hideyuki Shimizu, Junjiro Kobayashi, Tomoyuki Fujita

Research output: Contribution to journalArticle

Abstract

Hemolysis is closely related with pump thrombosis and thromboembolic events in patients with continuous flow left ventricular assist devices. We retrospectively investigated the impact of early postoperative heparinization on hemolysis in patients with HeartMate II devices. From April 2013 to August 2017, 83 patients (age 45 ± 12 years; 20 females; body surface area 1.6 ± 0.2 m2) underwent HeartMate II implantation. Postoperative heparinization was started when hemostasis was achieved and continued until full warfarinization. Hemolysis was defined in accordance with the Interagency Registry for Mechanically Assisted Circulatory Support definitions. The average support period was 22 ± 14 months. The 6-, 12-, and 24-month freedoms from hemolysis were 72%, 70%, and 67%, respectively. Pump thrombosis developed in five (6%) patients and four (5%) required pump exchanges. Heparin start time was significantly later in patients with hemolysis (43 ± 23 h after implantation) versus those without (29 ± 14 h after implantation; p = 0.01). Receiver operating characteristic analysis determined the cut-off point of heparin start time as 29 h. The patients were divided into the early group (heparin start time < 29 h; n = 29), and the late group (heparin start time > 29 h; n = 54). The respective 6-, 12-, and 24-month freedoms from hemolysis for the early group (86%, 86%, and 86%, respectively) were significantly higher than those for the late group (49%, 47%, and 44%, respectively; p = 0.002). Being in the late group was an independent risk factor for hemolysis (hazard ratio 4.09). Early postoperative heparinization (within 29 h after implantation) reduces hemolysis in patients with HeartMate II devices.

Original languageEnglish
JournalJournal of Artificial Organs
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Hemolysis
Heparin
Pumps
Equipment and Supplies
Left ventricular assist devices
Hazards
Thrombosis
Heart-Assist Devices
Body Surface Area
Hemostasis
ROC Curve
Registries

Keywords

  • Cerebral vascular accident
  • HeartMate II
  • Hemolysis
  • Postoperative heparinization

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine

Cite this

Matsumoto, Y., Fukushima, S., Shimahara, Y., Kawamoto, N., Tadokoro, N., Kuroda, K., ... Fujita, T. (Accepted/In press). Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices. Journal of Artificial Organs. https://doi.org/10.1007/s10047-019-01129-z

Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices. / Matsumoto, Yorihiko; Fukushima, Satsuki; Shimahara, Yusuke; Kawamoto, Naonori; Tadokoro, Naoki; Kuroda, Kensuke; Nakajima, Seiko; Watanabe, Takuya; Seguchi, Osamu; Yanase, Masanobu; Fukushima, Norihide; Shimizu, Hideyuki; Kobayashi, Junjiro; Fujita, Tomoyuki.

In: Journal of Artificial Organs, 01.01.2019.

Research output: Contribution to journalArticle

Matsumoto, Y, Fukushima, S, Shimahara, Y, Kawamoto, N, Tadokoro, N, Kuroda, K, Nakajima, S, Watanabe, T, Seguchi, O, Yanase, M, Fukushima, N, Shimizu, H, Kobayashi, J & Fujita, T 2019, 'Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices', Journal of Artificial Organs. https://doi.org/10.1007/s10047-019-01129-z
Matsumoto, Yorihiko ; Fukushima, Satsuki ; Shimahara, Yusuke ; Kawamoto, Naonori ; Tadokoro, Naoki ; Kuroda, Kensuke ; Nakajima, Seiko ; Watanabe, Takuya ; Seguchi, Osamu ; Yanase, Masanobu ; Fukushima, Norihide ; Shimizu, Hideyuki ; Kobayashi, Junjiro ; Fujita, Tomoyuki. / Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices. In: Journal of Artificial Organs. 2019.
@article{e683466e9eb7478fb56d3542e488873e,
title = "Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices",
abstract = "Hemolysis is closely related with pump thrombosis and thromboembolic events in patients with continuous flow left ventricular assist devices. We retrospectively investigated the impact of early postoperative heparinization on hemolysis in patients with HeartMate II devices. From April 2013 to August 2017, 83 patients (age 45 ± 12 years; 20 females; body surface area 1.6 ± 0.2 m2) underwent HeartMate II implantation. Postoperative heparinization was started when hemostasis was achieved and continued until full warfarinization. Hemolysis was defined in accordance with the Interagency Registry for Mechanically Assisted Circulatory Support definitions. The average support period was 22 ± 14 months. The 6-, 12-, and 24-month freedoms from hemolysis were 72{\%}, 70{\%}, and 67{\%}, respectively. Pump thrombosis developed in five (6{\%}) patients and four (5{\%}) required pump exchanges. Heparin start time was significantly later in patients with hemolysis (43 ± 23 h after implantation) versus those without (29 ± 14 h after implantation; p = 0.01). Receiver operating characteristic analysis determined the cut-off point of heparin start time as 29 h. The patients were divided into the early group (heparin start time < 29 h; n = 29), and the late group (heparin start time > 29 h; n = 54). The respective 6-, 12-, and 24-month freedoms from hemolysis for the early group (86{\%}, 86{\%}, and 86{\%}, respectively) were significantly higher than those for the late group (49{\%}, 47{\%}, and 44{\%}, respectively; p = 0.002). Being in the late group was an independent risk factor for hemolysis (hazard ratio 4.09). Early postoperative heparinization (within 29 h after implantation) reduces hemolysis in patients with HeartMate II devices.",
keywords = "Cerebral vascular accident, HeartMate II, Hemolysis, Postoperative heparinization",
author = "Yorihiko Matsumoto and Satsuki Fukushima and Yusuke Shimahara and Naonori Kawamoto and Naoki Tadokoro and Kensuke Kuroda and Seiko Nakajima and Takuya Watanabe and Osamu Seguchi and Masanobu Yanase and Norihide Fukushima and Hideyuki Shimizu and Junjiro Kobayashi and Tomoyuki Fujita",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10047-019-01129-z",
language = "English",
journal = "Journal of Artificial Organs",
issn = "1434-7229",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices

AU - Matsumoto, Yorihiko

AU - Fukushima, Satsuki

AU - Shimahara, Yusuke

AU - Kawamoto, Naonori

AU - Tadokoro, Naoki

AU - Kuroda, Kensuke

AU - Nakajima, Seiko

AU - Watanabe, Takuya

AU - Seguchi, Osamu

AU - Yanase, Masanobu

AU - Fukushima, Norihide

AU - Shimizu, Hideyuki

AU - Kobayashi, Junjiro

AU - Fujita, Tomoyuki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Hemolysis is closely related with pump thrombosis and thromboembolic events in patients with continuous flow left ventricular assist devices. We retrospectively investigated the impact of early postoperative heparinization on hemolysis in patients with HeartMate II devices. From April 2013 to August 2017, 83 patients (age 45 ± 12 years; 20 females; body surface area 1.6 ± 0.2 m2) underwent HeartMate II implantation. Postoperative heparinization was started when hemostasis was achieved and continued until full warfarinization. Hemolysis was defined in accordance with the Interagency Registry for Mechanically Assisted Circulatory Support definitions. The average support period was 22 ± 14 months. The 6-, 12-, and 24-month freedoms from hemolysis were 72%, 70%, and 67%, respectively. Pump thrombosis developed in five (6%) patients and four (5%) required pump exchanges. Heparin start time was significantly later in patients with hemolysis (43 ± 23 h after implantation) versus those without (29 ± 14 h after implantation; p = 0.01). Receiver operating characteristic analysis determined the cut-off point of heparin start time as 29 h. The patients were divided into the early group (heparin start time < 29 h; n = 29), and the late group (heparin start time > 29 h; n = 54). The respective 6-, 12-, and 24-month freedoms from hemolysis for the early group (86%, 86%, and 86%, respectively) were significantly higher than those for the late group (49%, 47%, and 44%, respectively; p = 0.002). Being in the late group was an independent risk factor for hemolysis (hazard ratio 4.09). Early postoperative heparinization (within 29 h after implantation) reduces hemolysis in patients with HeartMate II devices.

AB - Hemolysis is closely related with pump thrombosis and thromboembolic events in patients with continuous flow left ventricular assist devices. We retrospectively investigated the impact of early postoperative heparinization on hemolysis in patients with HeartMate II devices. From April 2013 to August 2017, 83 patients (age 45 ± 12 years; 20 females; body surface area 1.6 ± 0.2 m2) underwent HeartMate II implantation. Postoperative heparinization was started when hemostasis was achieved and continued until full warfarinization. Hemolysis was defined in accordance with the Interagency Registry for Mechanically Assisted Circulatory Support definitions. The average support period was 22 ± 14 months. The 6-, 12-, and 24-month freedoms from hemolysis were 72%, 70%, and 67%, respectively. Pump thrombosis developed in five (6%) patients and four (5%) required pump exchanges. Heparin start time was significantly later in patients with hemolysis (43 ± 23 h after implantation) versus those without (29 ± 14 h after implantation; p = 0.01). Receiver operating characteristic analysis determined the cut-off point of heparin start time as 29 h. The patients were divided into the early group (heparin start time < 29 h; n = 29), and the late group (heparin start time > 29 h; n = 54). The respective 6-, 12-, and 24-month freedoms from hemolysis for the early group (86%, 86%, and 86%, respectively) were significantly higher than those for the late group (49%, 47%, and 44%, respectively; p = 0.002). Being in the late group was an independent risk factor for hemolysis (hazard ratio 4.09). Early postoperative heparinization (within 29 h after implantation) reduces hemolysis in patients with HeartMate II devices.

KW - Cerebral vascular accident

KW - HeartMate II

KW - Hemolysis

KW - Postoperative heparinization

UR - http://www.scopus.com/inward/record.url?scp=85072131087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072131087&partnerID=8YFLogxK

U2 - 10.1007/s10047-019-01129-z

DO - 10.1007/s10047-019-01129-z

M3 - Article

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

SN - 1434-7229

ER -